Medical ethicists have traditionally referred to beneficence, nonmaleficence,
respect for autonomy, and justice as fundamental principles of medical ethics.1 In some cases, however, adherence to these principles
produces competing ethical obligations. Such is the dilemma when a patient
with early Huntington disease (HD) forbids her physician to disclose this
diagnosis to her daughter. The daughter is a patient of the same physician;
she has a 50% chance of inheriting the HD mutation, which inevitably causes
the disease.
The principle of respect for autonomy suggests that the physician defer
to the mother's wish and not disclose her diagnosis. On the other hand, the
principle of beneficence is most relevant to the physician's relationship
with the daughter.2 The beneficent act would
be to inform the daughter of her risk for HD so that she can decide whether
to receive genetic testing and potentially prevent transmitting the mutation
to her children.3 Although some authors
have suggested that patients have a "right not to know" about their risk for
serious genetic diseases that lack effective treatments,4 informing
the daughter that she is at risk would preserve her right not to know whether
she has the HD mutation while offering her the opportunity for testing.
Unfortunately, no inherent feature of the 4 principles provides a method
for untangling such conflicting obligations.5 They
describe the physician's obligations to each patient individually but do not
shed much light on how to balance incompatible duties. Thus, the physician
must look elsewhere for guidance when basic principles alone are inadequate
to resolve an ethical conflict. What method should the physician use in resolving
this dilemma? Some ethicists would suggest that the physician ought to reason
inductively on the basis of similarity to previous cases (a "bottom-up" approach),
while others would favor a "top-down" approach, in which the physician would
select general principles that describe a way to sort out competing obligations,
and then apply these to the specific case. In practice, however, the choice
of problem-solving strategy may be irrelevant, as different approaches may
nonetheless yield the same solutions.6 Of
course, there are cases in which rational people disagree about both action
and rationale; sorting out these differences is indeed a major project of
ethicists. The relevant point, however, is that the physician might avoid
the gridlock of conflicting principles by applying consensus-based ethical
guidelines. This approach would circumvent the dilemma of selecting strictly
a top-down or bottom-up approach, and instead incorporate the strengths of
both.
The physician could refer to the Institute of Medicine (IOM) Committee
on Assessing Genetic Risks guidelines.7 These
guidelines are congruent with those of other governmental commissions on bioethics,
including the President's Commission for the Study of Ethical Problems in
Medicine and Biomedical and Behavior Research8 and
the British Nuffield Council on Bioethics.9 This
congruence is significant because it broadens the population across which
consensus was reached; assessing both US and British recommendations may help
in reducing the influence of sociocultural bias and popular opinion on consensus.
The IOM guidelines, furthermore, are consistent with the "duty to warn" set
forth by the Tarasoff case, which established that
clinicians have a duty to warn a third party that a patient had threatened
harm to that person, even if this means breaching confidentiality.2
According to IOM guidelines,7 several
criteria must be met before confidentiality can be broken. First, all attempts
to elicit voluntary disclosure must have failed. In this case, the physician
should not only encourage the mother but also ensure that she understands
the implications of her decision. The mother, however, is adamant in her refusal
to disclose.
The next 2 criteria, which are most easily considered together, are
whether there is a high probability of irreversible harm to the daughter and
whether the harm would be prevented by disclosing the mother's diagnosis to
her. Certainly, developing HD would be harmful to the daughter. However, as
there is no treatment for asymptomatic persons with the HD mutation,10 informing the daughter of her risk would not improve
her outcome medically. Beyond physical harm from HD itself, the daughter could
experience psychological harm were she to pass the HD mutation to her child
or if she were eventually diagnosed with HD and wished that she had been tested
for the mutation earlier.
Finally, what would be the consequences if the daughter were unknowingly
to pass the HD mutation to her child? Without knowing the daughter's genotype,
her child would have a 25% risk of having the HD mutation; a knowledge of
her genotype would establish the risk as either 50% or 0%, depending on whether
she carried the mutation. This risk of inheriting the HD mutation represents
a significant possibility for irreversible, serious harm to the child. However,
the issue of whether a child is harmed by being born with a genetic disease
vs never being born is quite murky.11 Currently
the daughter is only considering starting a family, so there is no immediate
risk of harm to a potential child. Further discussions with the daughter could
determine how soon she might try to conceive or if she is particularly concerned
about any risks she might have of genetic diseases.
Based on IOM guidelines, the physician is not justified in disclosing
the mother's diagnosis. Yet how can one be confident that merely applying
abstract guidelines will yield a tenable solution to this dilemma? The physician
might also use a casuistic approach, using case-based analysis or analogy
to compare the reasoning applied to this case with similar ones in the past.
In the 1995 Pate v Threkel case,12 the
highest state court in Florida unanimously held that a physician has a duty
to warn a third party about a genetically inherited disease. The plaintiff,
who had medullary thyroid carcinoma, sued the physician who had previously
treated her mother for the same disease, alleging that the physician was negligent
in not disclosing to the plaintiff her risk of the disease. The court stated
that the physician had a duty to warn the plaintiff about the risks of genetic
transmission, but in light of state confidentiality laws, this duty was satisfied
by warning the mother—not the plaintiff directly—of the possibility
of genetic transmission. Despite the fact that the plaintiff was directly
harmed by the lack of knowledge about her mother's condition (medullary thyroid
cancer carries a better prognosis with earlier detection), the court's decision
emphasizes respect for confidentiality over acting beneficently toward relatives.
The reasoning presented here—that unless there is a high probability
of serious harm to a third party, confidentiality ought to be respected—is
therefore also supported by case law.
What, then, has become of the physician's obligation to act beneficently
toward the daughter? It leaves behind what Nozick13 termed
a moral trace—that is, a residual attitude
or obligation that remains after a prima facie principle has been overridden.
The physician's residual obligation is to strongly encourage the mother to
inform the daughter herself by exploring the mother's reasons for not wanting
to "burden" her daughter and perhaps by using motivational interviewing techniques
to overcome her resistance. The physician should emphasize to the mother that
fully involving her family in her care, particularly as the disease progresses,
could result in a better quality of life.14 Additionally,
although genetic counseling is typically nondirective, it may be appropriate
in this case for a genetic counselor to advise the mother to disclose her
diagnosis. In the end, however, the decision to disclose the diagnosis ought
to be the mother's, and solely hers.
How much confidence ought the physician to have in this decision? Despite
the reasoning process described herein, it is still possible that cultural
or social factors influence the analysis. For instance, popular attitudes
toward paternalism and patient autonomy have changed dramatically over the
past century. However, it is more important to ask whether cultural or social
bias necessarily has a deleterious impact on ethical decision making. Indeed,
one might argue that an ethical position must be commensurate with widely
held cultural values. Ultimately, the physician must simply trust that appropriate
decision making techniques will yield ethically tenable solutions to difficult
problems.
1.Nicholson RH. Limitations of the four principles. In: Gillon R, ed. Principles of Health Care Ethics. New York, NY: John Wiley & Sons; 1994.
2.Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 5th ed. New York, NY: Oxford University Press; 2001.
3.Goizet C, Lesca G, Durr A.for the French Group for Presymptomatic Testing in Neurogenetic Disorders. Presymptomatic testing in Huntington's disease and autosomal dominant
cerebellar ataxias.
Neurology.2002;59:1330-1336.Google Scholar 4.Terrenoire G. Huntington's disease and the ethics of genetic prediction.
J Med Ethics.1992;18:79-85.Google Scholar 5.Clouser DK, Gert B. A critique of principalism.
J Med Philos.1990;15:219-236.Google Scholar 6.Jonsen AR, Toulmin S. The Abuse of Casuistry: A History of Moral Reasoning. Berkeley: University of California Press; 1988.
7.Andrews LB, Fullarton JE, Holtzman NA, Motulsky AG. Assessing Genetic Risks: Implications for Health
and Social Policy. Washington, DC: National Academy Press; 1994.
8.The President's Commission for the Study of Ethical Problems in Medicine
and Biomedical Behavioral Research. Screening and Counseling for Genetic Conditions:
A Report on the Ethical, Social, and Legal Implications of Genetic Screening,
Counseling, and Education Programs. Washington, DC: US Government Printing Office; 1983.
9.Church of Scotland Board of Social Responsibility. Genetics: the British conversation and a Christian response. In: Lammers SE, Verhey A, eds. On Moral Medicine:
Theological Perspectives in Medical Ethics. 2nd ed. Grand Rapids, Mich:
WB Eerdmans Publishing Co; 1998.
10.Feigin A, Zgaljardic D. Recent advances in Huntington's disease: implications for experimental
therapeutics.
Curr Opin Neurol.2002;15:483-489.Google Scholar 11.Fagot-Largeault A. Abortion and arguments from potential. In: Gillon R, ed. Principles of Health Care Ethics. New York, NY: John Wiley & Sons; 1994.
12.McAbee GN, Sherman J, Davidoff-Feldman B. Physician's duty to warn third parties about the risk of genetic diseases.
Pediatrics.1998;102:140-142.Google Scholar 13.Nozick R. Moral complications and moral structures.
National Law Forum.1968;13:1-50.Google Scholar 14.Lynch A. Commentary: the price of silence.
Hastings Cent Rep.1990;20:31-35.Google Scholar